Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma

The aim of this study was to assess the clinical characteristics and outcome of patients with either primary peritoneal carcinoma (PPC) or ovarian serous carcinoma (OSC) treated with paclitaxel plus carboplatin chemotherapy. We retrospectively identified 22 PPC patients and 55 stage III–IV OSC patie...

Full description

Bibliographic Details
Main Authors: R. Kawaguchi, Y. Tanase, S. Haruta, A. Nagai, S. Yoshida, N. Furukawa, H. Ooi, K. Kobayashi
Format: Article
Language:English
Published: Karger Publishers 2012-04-01
Series:Case Reports in Oncology
Subjects:
Primary peritoneal carcinoma
Paclitaxel
Carboplatin
Online Access:http://www.karger.com/Article/FullText/338402

Internet

http://www.karger.com/Article/FullText/338402

Similar Items